| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC2829 |
| Trial ID | NCT05099094 |
| Disease | Retinal and Choroidal Neovascularization Disease |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | BD311 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Safety and Efficacy Study of VEGFA-targeting Gene Therapy to Treat Refractory Retinal and Choroidal Neovascularization Diseases |
| Year | 2021 |
| Country | China |
| Company sponsor | Shanghai BDgene Co., Ltd. |
| Other ID(s) | BD311 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||
|
|||||||